[Open positions] 12 high-level PhD on innovative metastatic melanoma treatment
14 April 2023
Melomanes is an Horizon Europe funded project that aims to train 12 PhDs for the development of an innovative therapy for metastatic melanoma, combining magnetic nanoparticles with CAR-T cells.
We are currently recruiting our 12 doctoral researchers on a wide range of disciplines (physical chemistry, informatics, toxicology, biology, health science, ethics, etc) in leading institutions all over Europe.
12 PhD projects in leading institutions over Europe to develop new strategies for metastatic melanoma treatment
Each PhD candidate will benefit from a wide-ranging training between research centers, universities and industries. Our aim is to allow a new generation of highly skilled doctoral researchers to emerge with a high-level training in particular in the multidisciplinary field of nanomedicine.
Funded by the European Union under the grant agreement 101073025. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.